Cost Reduction and Operational Restructuring
Reduced operating expenses by over $0.5 million compared to the same period last year, while maintaining stable revenue performance. These results reflect the early benefits of the company's transformational strategy.
Expansion in Dental Segment
Expanded direct sales programs in North America and advanced international registrations for the STA Single Tooth Anesthesia System. International dental sales increased year-over-year, partially offsetting the decline in domestic revenue.
Medicare Payment Rate Assignments for CompuFlo
CompuFlo system secured Medicare payment rate assignments under CPT Code 0777T in 3 jurisdictions, supported by 2 MACs, Novitas and First Coast, including states like New Jersey, Texas, and Florida.
Stable Revenue and Positive Outlook
For the 3 months and 9 months ended September 30, 2025, revenue was $2.4 million and $6.9 million, respectively, compared to $2.5 million and $6.6 million for the same period in 2024. Gross profit remained stable.